Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Nappalli D, Lingappa A. Oral manifestations in transplant patients. Dent Res J (Isfahan). 2015;12(3):199-208.
Lin Y, Li S, Mo C, Liu H, Bi J, Xu S, Jia B, Liu C, Liu Z. Oral microbial changes and oral disease management before and after the treatment of hematological malignancies: a narrative review. Clin Oral Investig. 2023.
Sotozono C, Inatomi T, Nakamura T, Ueta M, Imai K, Fukuoka H, Komai S, Ishida G, Kitazawa K, Yokoi N, et al. Oral Mucosal Epithelial Transplantation and Limbal-Rigid Contact Lens: A Therapeutic Modality for the Treatment of Severe Ocular Surface Disorders. Cornea. 2020;39 Suppl 1:S19-S27.
Legert KGarming, Ringdén O, Remberger M, Törlén J, Mattsson J, Dahllöf G. Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis. Oral Dis. 2020.
Pels E. Oral mucositis in children suffering from acute lymphoblastic leukaemia. Contemp Oncol (Pozn). 2012;16(1):12-15.
Ali M, Kerio AAli, Khattak TAzam, Hussain M, Khan MAli, Abbas Y. Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation. J Coll Physicians Surg Pak. 2023;33(7):804-808.
Rodriguez N, Lee J, Flynn L, Murray F, Devlin SM, Soto C, Cho C, Dahi P, Giralt S, Perales M-A, et al. Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation. Transplant Cell Ther. 2021.
Kaveh-Ahangaran R, Abdollahi M, Vaezi M, Kasaeian A, Bahlouli Z, Janbabaei G, Mojtahedzadeh A, Mojtahedzadeh M, Djalalinia S, Shahrami B. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis. Daru. 2024.
Abdel-Kader MAhmed, Abdelazeem AFarouk, Ahmed NEl-Moataz, Khalil YMohamed, Mostafa MIbrahim. Oral rehabilitation of a case with regional odontodysplasia using a regenerative approach-A case report and a review of literature. Spec Care Dentist. 2019.
Costa ALF, Santos BA, Torregrossa VR, Miranda ECM, Vigorito AC, Palmieri M, Ricardo ALF, Sarmento DJS, Mamana AC, Tozetto-Mendoza TR, et al. Oral shedding of CMV and HSV-1 in hematopoietic stem cell transplantation patients. Oral Dis. 2020.
Yousefi L, Leylabadlo HEbrahimzad, Pourlak T, Eslami H, Taghizadeh S, Ganbarov K, Yousefi M, Tanomand A, Yousefi B, Kafil HSamadi. Oral spirochetes: Pathogenic mechanisms in periodontal disease. Microb Pathog. 2020:104193.
Monteiro M-F, Lemos J-G, Pontes F-S, Silva A-C, Silva M-H, Silva N-F, Souza L-L, Uchôa D-C, Pontes H-A. Oral squamous cell carcinoma arising from areas of Graft-versus-host disease: A systematic review. Med Oral Patol Oral Cir Bucal. 2023.
Dipietro LA. Oral Stem Cells: The Fountain of Youth for Epithelialization and Wound Therapy?. Adv Wound Care (New Rochelle). 2014;3(7):465-467.
Liu B, Cai J, Li W, Liu G, Chen J. Oral submucous fibrosis induced by graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Oral Oncol. 2022;130:105919.
Venugopal S, Shallis RM, Zeidan AM. Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress. Expert Rev Anticancer Ther. 2023:1-9.
Li M, Zheng S, Gong Q, Zhuang H, Wu Z, Wang P, Zhang X, Xu R. An oral triple pill-based cocktail effectively controls acute myeloid leukemia with high translation. Biomed Pharmacother. 2023;167:115584.
Ryu HSeok, Abueva C, Padalhin A, Park SYoung, Yoo SHyeon, Seo HHyon, Chung P-S, Woo SHoon. Oral ulcer treatment using human tonsil-derived mesenchymal stem cells encapsulated in trimethyl chitosan hydrogel: an animal model study. Stem Cell Res Ther. 2024;15(1):103.
Morrisette T, Van Matre AG, Miller MA, Mueller SW, Bajrovic V, Abidi MZ, Benamu E, Kaiser JN, Barber GR, Chase S, et al. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplant and Hematologic Malignancy Population. Biol Blood Marrow Transplant. 2019.
Kitaura Y, Nakamura U, Awada C, Yamaguchi M, Kim M, Ikeda Y, Matsuo Y, Moriishi T, Sawase T, Chung U-I, et al. Orally administrable peptides derived from egg yolk promote skeletal repair and ameliorate degenerative skeletal disorders in mouse models. Regen Ther. 2022;21:584-595.
Hanaford AR, Alt J, Rais R, Wang SZ, Kaur H, Thorek DLJ, Eberhart CG, Slusher BS, Martin AM, Raabe EH. Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma. Transl Oncol. 2019;12(10):1314-1322.
Brandau S, Bruderek K, Hestermann K, Görtz G-E, Horstmann M, Mattheis S, Lang S, Eckstein A, Berchner-Pfannschmidt U. Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells. Invest Ophthalmol Vis Sci. 2015;56(11):6549-6557.
Chen TH, Roelofs KA, Goh T, Pullarkat S, Goldberg RA, Rootman DB. Orbital Involvement in Acute Adult Leukemias: Case Series and Review of Literature. Ophthalmic Plast Reconstr Surg. 2023.
Melke J, Zhao F, Ito K, Hofmann S. Orbital seeding of mesenchymal stromal cells increases osteogenic differentiation and bone-like tissue formation. J Orthop Res. 2020.
Babalian A, Eichenberger S, Bilella A, Girard F, Szabolcsi V, Roccaro D, Alvarez-Bolado G, Xu C, Celio MR. The orbitofrontal cortex projects to the parvafox nucleus of the ventrolateral hypothalamus and to its targets in the ventromedial periaqueductal grey matter. Brain Struct Funct. 2018.
Shao X, Yang Y, Liu Y, Wang Y, Zhao Y, Yu X, Liu J, Li Y-X, Wang Y-L. Orchestrated feedback regulation between melatonin and sex hormones involving GPER1-PKA-CREB signaling in the placenta. J Pineal Res. 2023:e12913.